These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 1658645

  • 1. In vivo effects of sera from Guillain-Barré subgroups: an electrophysiological and histological study on rat nerves.
    Oomes PG, van der Meché FG, Markus-Silvis L, Meulstee J, Kleyweg RP.
    Muscle Nerve; 1991 Oct; 14(10):1013-20. PubMed ID: 1658645
    [Abstract] [Full Text] [Related]

  • 2. Demyelination in vivo by Guillain-Barré syndrome and other human serum.
    Brown MJ, Rosen JL, Lisak RP.
    Muscle Nerve; 1987 Oct; 10(3):263-71. PubMed ID: 3561445
    [Abstract] [Full Text] [Related]

  • 3. Demyelination induced by serum from patients with Guillain-Barré syndrome.
    Harrison BM, Hansen LA, Pollard JD, McLeod JG.
    Ann Neurol; 1984 Feb; 15(2):163-70. PubMed ID: 6703656
    [Abstract] [Full Text] [Related]

  • 4. In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome.
    Saida T, Saida K, Lisak RP, Brown MJ, Silberberg DH, Asbury AK.
    Ann Neurol; 1982 Jan; 11(1):69-75. PubMed ID: 7059130
    [Abstract] [Full Text] [Related]

  • 5. [Electrophysiological and morphological effects of the injection of Guillain-Barré sera in the sciatic nerve of the rat (author's transl)].
    Sumner A, Said G, Idy I, Metral S.
    Rev Neurol (Paris); 1982 Jan; 138(1):17-24. PubMed ID: 7100734
    [Abstract] [Full Text] [Related]

  • 6. Electrophysiological studies of Guillain-Barré syndrome with different susceptibilities to develop EAN serum on 2 strains of rats.
    Low PA, Schmelzer J, Dyck PJ, Kelly JJ.
    Electroencephalogr Clin Neurophysiol Suppl; 1982 Jan; 36():81-90. PubMed ID: 6984386
    [Abstract] [Full Text] [Related]

  • 7. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC, van Doorn PA, Schmitz PI, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkass H, van der Meché FG.
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [Abstract] [Full Text] [Related]

  • 8. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J, Yuan J, Hao H.
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [Abstract] [Full Text] [Related]

  • 9. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL.
    Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
    [Abstract] [Full Text] [Related]

  • 10. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study.
    Buchwald B, Toyka KV, Zielasek J, Weishaupt A, Schweiger S, Dudel J.
    Ann Neurol; 1998 Dec; 44(6):913-22. PubMed ID: 9851436
    [Abstract] [Full Text] [Related]

  • 11. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
    Shimoya K, Ohnishi A, Hashimoto T, Yuki N.
    Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
    [Abstract] [Full Text] [Related]

  • 12. Serum-induced demyelination: an electrophysiological and histological study.
    Pollard JD, Harrison B, Gatenby P.
    Clin Exp Neurol; 1981 Feb; 18():70-80. PubMed ID: 6926394
    [Abstract] [Full Text] [Related]

  • 13. [Antiglycolipid antibody in inflammatory neuropathy].
    Kusunoki S.
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1370-2. PubMed ID: 8752399
    [Abstract] [Full Text] [Related]

  • 14. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
    Oomes PG, Jacobs BC, Hazenberg MP, Bänffer JR, van der Meché FG.
    Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
    [Abstract] [Full Text] [Related]

  • 15. [Prevalence and characteristics of Guillain-Barré syndromes associated with Campylobacter jejuni and cytomegalovirus in greater Paris].
    Sivadon V, Orlikowski D, Rozenberg F, Quincampoix JC, Caudie C, Durand MC, Fauchère JL, Sharshar T, Raphaël JC, Gaillard JL.
    Pathol Biol (Paris); 2005 Aug; 53(8-9):536-8. PubMed ID: 16084033
    [Abstract] [Full Text] [Related]

  • 16. In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes.
    Sawant-Mane S, Clark MB, Koski CL.
    Ann Neurol; 1991 Apr; 29(4):397-404. PubMed ID: 1718212
    [Abstract] [Full Text] [Related]

  • 17. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K, Koga M, Takahashi M, Hirata K, Yuki N.
    J Neurol Sci; 2006 Jul 15; 246(1-2):163-8. PubMed ID: 16600306
    [Abstract] [Full Text] [Related]

  • 18. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV.
    Ann Neurol; 1998 Nov 15; 44(5):780-8. PubMed ID: 9818934
    [Abstract] [Full Text] [Related]

  • 19. [Acute polyradiculoneuropathy of Guillain-Barré. Critical review of potential etiopathogeneses].
    Guadagnino M, Petitto F.
    Riv Neurol; 1985 Nov 15; 55(6):402-23. PubMed ID: 3008302
    [Abstract] [Full Text] [Related]

  • 20. Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barré syndrome.
    Sinha S, Prasad KN, Pradhan S, Jain D, Jha S.
    Trans R Soc Trop Med Hyg; 2004 Jun 15; 98(6):342-6. PubMed ID: 15099989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.